Eli Lilly Bets on GLP-1s to Reclaim Trillion Dollar Value
Eli Lilly, led by CEO Dave Ricks, became the first $1 trillion pharmaceutical company, primarily through its popular weight-loss and diabetes medications. Over 60% of its revenue now depends on these drugs, posing risks related to its reliance on them.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)